The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report.
In recent years, lumpectomy combined with breast irradiation and chemotherapy, as a part of conservation therapy for breast cancer, has well-established results. Little has been published on reduction mammoplasty for breast-irradiated patients. These patients have increased risks of nipple necrosis, wound complications, and delayed healing. Breast reduction techniques that rely on minimum skin undermining combined with the use of buflomedil may prevent major postoperative complications in breast-irradiated patients. Buflomedil was administered intraoperatively and for 14 days after the procedure. The use of buflomedil in reduction mammaplasty for a previously irradiated breast patient has not been heretofore described. The case of a 58-year-old woman who underwent bilateral breast reduction after breast conservation therapy is reported.
Sterodimas
A
A
Department of Plastic Surgery, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ 22280-020, Brazil. steroaris@yahoo.com
Vargas
A
A
Radwanski
H N
HN
Pitanguy
I
I
D001940:Breast / Q000473:pathology* / Q000528:radiation effects / Q000601:surgery; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D015412:Mastectomy, Segmental / Q000379:methods*; D008875:Middle Aged; D011759:Pyrrolidines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D011759:Pyrrolidines; D014665:Vasodilator Agents; C010651:buflomedil